Tumor necrosis factor alpha (TNF-α) is a pro-inflammatory key molecule promoting the perpetuation of chronic intestinal inflammation in IBD, and anti TNF-α therapies are potent treatment options within current IBD-therapies for a substantial portion of IBD patients (59,60,71). This evidence concerns the gene TNF and inflammatory bowel disease.